Search Results - "SCHWENKENBECHER, PHILIPP"
-
1
Common and uncommon neurological manifestations of neuroborreliosis leading to hospitalization
Published in BMC infectious diseases (21-01-2017)“…Neuroborreliosis represents a relevant infectious disease and can cause a variety of neurological manifestations. Different stages and syndromes are described…”
Get full text
Journal Article -
2
Varicella zoster virus infections in neurological patients: a clinical study
Published in BMC infectious diseases (25-05-2018)“…Varicella zoster virus (VZV) reactivation is a common infectious disease in neurology and VZV the second most frequent virus detected in encephalitis. This…”
Get full text
Journal Article -
3
The Persisting Significance of Oligoclonal Bands in the Dawning Era of Kappa Free Light Chains for the Diagnosis of Multiple Sclerosis
Published in International journal of molecular sciences (29-11-2018)“…The latest revision of the McDonald criteria of 2017 considers the evidence of an intrathecal immunoglobulin (IgG) synthesis as a diagnostic criterion for…”
Get full text
Journal Article -
4
Impact of the McDonald Criteria 2017 on Early Diagnosis of Relapsing-Remitting Multiple Sclerosis
Published in Frontiers in neurology (15-03-2019)“…Multiple sclerosis is a chronic immune mediated demyelinating disease leading to neurological disabilities that need to be diagnosed and treated early…”
Get full text
Journal Article -
5
Clinical and paraclinical characteristics of optic neuritis in the context of the McDonald criteria 2017
Published in Scientific reports (27-03-2024)“…Optic neuritis is often an initial symptom in multiple sclerosis (MS) or clinically isolated syndrome (CIS), yet comprehensive studies using the 2017 McDonald…”
Get full text
Journal Article -
6
Leptomeningeal Metastasis: The Role of Cerebrospinal Fluid Diagnostics
Published in Frontiers in neurology (20-08-2019)“…Metastatic spread into the cerebrospinal fluid (CSF) represents a severe complication of malignant disease with poor prognosis. Although early diagnosis is…”
Get full text
Journal Article -
7
Ocrelizumab Depletes CD20⁺ T Cells in Multiple Sclerosis Patients
Published in Cells (Basel, Switzerland) (28-12-2018)“…Ocrelizumab, a humanized monoclonal anti-CD20 antibody, has shown pronounced effects in reduction of disease activity in multiple sclerosis (MS) patients and…”
Get full text
Journal Article -
8
Fumaric Acids Directly Influence Gene Expression of Neuroprotective Factors in Rodent Microglia
Published in International journal of molecular sciences (15-01-2019)“…Dimethylfumarate (DMF) has been approved the for treatment of relapsing-remitting multiple sclerosis. The mode of action of DMF and its assumed active primary…”
Get full text
Journal Article -
9
Radiotherapy in patients with brain metastases with and without concomitant immunotherapy: comparison of patient outcome and neurotoxicity
Published in Discover. Oncology (15-11-2024)“…Background/Aim Recently, immune checkpoint inhibitors (ICI) have been added to the treatment of brain metastases. While combining radiotherapy and ICI can…”
Get full text
Journal Article -
10
The Increasing Role of Kappa Free Light Chains in the Diagnosis of Multiple Sclerosis
Published in Cells (Basel, Switzerland) (06-11-2021)“…Free light chains (FLC) are a promising biomarker to detect intrathecal inflammation in patients with inflammatory central nervous system (CNS) diseases,…”
Get full text
Journal Article -
11
Clinically Isolated Syndrome According to McDonald 2010: Intrathecal IgG Synthesis Still Predictive for Conversion to Multiple Sclerosis
Published in International journal of molecular sciences (27-09-2017)“…While the revised McDonald criteria of 2010 allow for the diagnosis of multiple sclerosis (MS) in an earlier stage, there is still a need to identify the risk…”
Get full text
Journal Article -
12
McDonald Criteria 2010 and 2005 Compared: Persistence of High Oligoclonal Band Prevalence Despite Almost Doubled Diagnostic Sensitivity
Published in International journal of molecular sciences (21-09-2016)“…The 2010 McDonald criteria were developed to allow a more rapid diagnosis of relapsing-remitting multiple sclerosis (MS) by only one MRI of the brain. Although…”
Get full text
Journal Article -
13
The Influence of Blood Contamination on Cerebrospinal Fluid Diagnostics
Published in Frontiers in neurology (12-06-2019)“…Blood contamination due to traumatic lumbar puncture presents a diagnostic pitfall in cerebrospinal fluid (CSF) analysis. It is controversially discussed if…”
Get full text
Journal Article -
14
Investigation of Oligoclonal IgG Bands in Tear Fluid of Multiple Sclerosis Patients
Published in Frontiers in immunology (17-05-2019)“…Oligoclonal IgG bands (OCB) in the cerebrospinal fluid (CSF) represent a typical marker for inflammation in multiple sclerosis (MS) patients and have a…”
Get full text
Journal Article -
15
Cerebrospinal fluid features in adults with enteroviral nervous system infection
Published in International journal of infectious diseases (01-03-2018)“…•The cerebrospinal fluid (CSF) cell count was normal in 15% of all patients.•Patients with normal CSF cell counts were older and less frequently had…”
Get full text
Journal Article -
16
Decreased Intrathecal Concentrations of Free Light Chains Kappa in Multiple Sclerosis Patients Taking Very High Effective Disease-Modifying Treatment
Published in Diagnostics (Basel) (16-03-2022)“…Free light chains kappa (FLCκ) in cerebrospinal fluid (CSF) are a part of the intrathecal immune response. This observational study was conducted to…”
Get full text
Journal Article -
17
Evidence of Oligoclonal Bands Does Not Exclude Non-Inflammatory Neurological Diseases
Published in Diagnostics (Basel) (28-12-2020)“…Cerebrospinal fluid analysis is an essential part of the diagnostic workup in various neurological disorders. Evidence of an intrathecal immunoglobulin…”
Get full text
Journal Article -
18
The Influence of Renal Function Impairment on Kappa Free Light Chains in Cerebrospinal Fluid
Published in Journal of Central Nervous System Disease (2021)“…Background The determination of kappa free light chains (KFLC) in cerebrospinal fluid (CSF) is an upcoming biomarker for the detection of an intrathecal…”
Get full text
Book Review Journal Article -
19
The Impact of Immunomodulatory Treatment on Kappa Free Light Chains as Biomarker in Neuroinflammation
Published in Cells (Basel, Switzerland) (31-03-2020)“…Kappa free light chains (KFLC) are a promising new biomarker to detect neuroinflammation. Still, the impact of pre-analytical effects on KFLC concentrations…”
Get full text
Journal Article -
20
Prevalence of comorbid autoimmune diseases and antibodies in newly diagnosed multiple sclerosis patients
Published in Neurological research and practice (12-11-2024)“…Abstract Background Diagnosing multiple sclerosis (MS) is challenging due to diverse symptoms and the absence of specific biomarkers. Concurrent autoimmune…”
Get full text
Journal Article